The Laurus Project® Supports Promising Research for the Prevention of Breast Cancer

Breast Cancer Non-Profit Supports Promising Research for the Prevention of Breast Cancer

The Laurus Project®, a breast cancer non-profit announced a new research grant to study breast cancer prevention through the use of cycles of a fasting mimicking diet (FMD) among women considered high-risk for the disease. The principal investigators are Dr. Valter Longo, Director of the Longevity Institute at the USC-Davis School of Gerontology, Los Angeles, and Senior Group Leader at IFOM (Molecular Oncology FIRC Institute) in Milan, Italy, and Dr. Mario Mirisola, University of Palermo, Department of Surgical, Oncological Disciplines, Palermo, Italy.

The research grant will be used to study how cyclic use of the FMD effects cancer rates in high risk women. Recent studies have shown that cycles of a diet that mimics fasting may have a cancer fighting effect in the body. Limited access to nutrients causes normal cells to go into a non-dividing, protected mode whereas cancer cells continue with unregulated growth and are more vulnerable to an attack by the immune system. Starvation conditions have also been found to induce stem cell-based regeneration of the immune system, strengthening its ability to identify and fight cancer cells.

“The research by Dr. Valter Longo may point to a new and groundbreaking way of lowering breast cancer risk, and preventing recurrence in previously diagnosed patients” said Teresa Lawsky, Founder and CEO of The Laurus Project.

Click HERE to watch a video about this ground breaking research.

About The Laurus Project
Founded in 2015, The Laurus Project is a not-for-profit that focuses on breast cancer prevention, treatment and quality of life for survivors. By supporting mission-aligned scientists, doctors and programs in their formative efforts as they search for new pathways in breast disease and identify targeted modes of therapy, The Laurus Project aims to save and improve the lives of individuals affected by breast cancer.

Leave a Reply

Your email address will not be published. Required fields are marked *